BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu BB, Leung KT, Poon EN. Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity. Int J Mol Sci 2022;23:1912. [PMID: 35163838 DOI: 10.3390/ijms23031912] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoang DH, Song M, Kovale LM, Tran QH, Choe W, Kang I, Kim SS, Ha J. Beta-naphthoflavone and doxorubicin synergistically enhance apoptosis in human lung cancer cells by inducing doxorubicin accumulation, mitochondrial ROS generation, and JNK pathway signaling. Biochemical and Biophysical Research Communications 2022;635:37-45. [DOI: 10.1016/j.bbrc.2022.10.015] [Reference Citation Analysis]
2 Wu L, Wang L, Du Y, Zhang Y, Ren J. Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.10.003] [Reference Citation Analysis]
3 Wang P, Fang Y, Liu Y, Yeh M. Merits of hiPSC-Derived Cardiomyocytes for In Vitro Research and Testing Drug Toxicity. Biomedicines 2022;10:2764. [DOI: 10.3390/biomedicines10112764] [Reference Citation Analysis]
4 Chang Y, Weng H, Tsai S, Fan FS. Disclosing an In-Frame Deletion of the Titin Gene as the Possible Predisposing Factor of Anthracycline-Induced Cardiomyopathy: A Case Report. IJMS 2022;23:9261. [DOI: 10.3390/ijms23169261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hosseini A, Safari MK, Rajabian A, Boroumand-Noughabi S, Eid AH, Al Dhaheri Y, Gumpricht E, Sahebkar A. Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats. Front Pharmacol 2022;13:909079. [PMID: 35754479 DOI: 10.3389/fphar.2022.909079] [Reference Citation Analysis]